🍽️ Lactococcus lactis
AI Engines For more Details: Perplexity Kagi Labs You
Check for interactions on Supp.AI | 📚 PubMed Citations | ⚗️ Compensation for antibiotic usage
Data Contradictions — Limits of Certainity
Impacted of Lactococcus lactis On Probiotics
| Rank | Probiotic | Impact |
|---|---|---|
| species | Escherichia coli | Reduces |
Bacteria Impacted by Lactococcus lactis
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
| Taxonomy | Rank | Effect | Citations | Notation |
|---|---|---|---|---|
| Enterobacteriaceae | family | Decreases | 👪 Source Study | |
| Escherichia | genus | Decreases | 📓 Source Study | |
| unclassified Escherichia | no rank | Decreases | 👪 Source Study | |
| unclassified Escherichia | no rank | Decreases | 👶 Source Study | |
| Escherichia sp. | species | Decreases | 📓 Source Study | |
| Escherichia albertii | species | Decreases | 👶 Source Study | |
| Escherichia coli | species | Decreases | 👶 Source Study | Diarrheal disease in children and travelers, Foodborne diarrhea outbreaks, hemorrhagic colitis, hemolytic-uremic syndrome |
| Escherichia fergusonii | species | Decreases | 👶 Source Study | |
| Escherichia marmotae | species | Decreases | 👶 Source Study |
Impact of Lactococcus lactis on Conditions from US National Library of Medicine
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
| Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
|---|---|---|---|
| Allergic Rhinitis (Hay Fever) | 0.5 | 0.5 | |
| Allergies | 0.4 | 0.3 | 0.33 |
| Allergy to milk products | 0.2 | 0.8 | -3 |
| Alzheimer's disease | 0.8 | 0.8 | |
| Amyotrophic lateral sclerosis (ALS) Motor Neuron | 0.8 | 0.4 | 1 |
| Ankylosing spondylitis | 0.9 | 0.3 | 2 |
| Anorexia Nervosa | 0.3 | 0.3 | |
| Antiphospholipid syndrome (APS) | 0.2 | 0.2 | |
| Asthma | 0.3 | 0.3 | 0 |
| Atrial fibrillation | 0.5 | -0.5 | |
| Autism | 0.8 | 0.8 | 0 |
| benign prostatic hyperplasia | 0.5 | 0.5 | |
| Bipolar Disorder | 0.5 | 0.5 | |
| Brain Trauma | 0.3 | 0.3 | |
| Carcinoma | 0.5 | 0.5 | |
| Celiac Disease | 0.4 | 0.3 | 0.33 |
| Chronic Kidney Disease | 0.5 | 0.5 | |
| Chronic Lyme | 0.3 | 0.3 | |
| Chronic Urticaria (Hives) | 0.7 | 0.7 | |
| Coagulation / Micro clot triggering bacteria | 0.7 | 0.7 | |
| Colorectal Cancer | 0.9 | 0.9 | |
| Constipation | 0.8 | 0.8 | |
| COVID-19 | 0.9 | 0.9 | |
| Crohn's Disease | 0.9 | 0.9 | |
| cystic fibrosis | 0.7 | 0.7 | |
| deep vein thrombosis | 0.7 | 0.7 | |
| Depression | 1.3 | 0.5 | 1.6 |
| Eczema | 0.8 | 0.8 | |
| Endometriosis | 0.9 | 0.9 | |
| Epilepsy | 0.5 | 0.5 | |
| Functional constipation / chronic idiopathic constipation | 0.9 | 0.9 | |
| gallstone disease (gsd) | 0.5 | 0.5 | |
| Generalized anxiety disorder | 0.7 | 0.7 | |
| Graves' disease | 0.3 | -0.3 | |
| Histamine Issues | 0.3 | 0.3 | |
| hyperglycemia | 0.5 | 0.5 | |
| hypertension (High Blood Pressure | 0.5 | 0.5 | |
| IgA nephropathy (IgAN) | 0.3 | 0.3 | |
| Inflammatory Bowel Disease | 0.7 | 0.7 | |
| Irritable Bowel Syndrome | 0.9 | 0.9 | |
| Liver Cirrhosis | 0.8 | 0.8 | |
| Long COVID | 0.8 | 0.8 | |
| Lung Cancer | 0.5 | 0.5 | |
| Mast Cell Issues / mastitis | 0.5 | 0.5 | |
| Metabolic Syndrome | 0.9 | 0.9 | |
| Mood Disorders | 1.3 | 0.8 | 0.63 |
| myasthenia gravis | 0.3 | -0.3 | |
| Neuropathy (all types) | 0.5 | -0.5 | |
| neuropsychiatric disorders (PANDAS, PANS) | 0.2 | 0.2 | |
| Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 0.8 | 0.8 | |
| Obesity | 0.8 | 0.8 | |
| obsessive-compulsive disorder | 0.9 | 0.9 | |
| Osteoarthritis | 0.5 | 0.5 | |
| Osteoporosis | 0.5 | 0.5 | |
| Parkinson's Disease | 0.4 | 0.5 | -0.25 |
| Polycystic ovary syndrome | 0.8 | 0.8 | |
| Postural orthostatic tachycardia syndrome | 0.3 | 0.3 | |
| Psoriasis | 0.2 | 0.2 | |
| rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 0.8 | 0.8 | |
| Schizophrenia | 0.3 | -0.3 | |
| Sjögren syndrome | 0.5 | 0.5 | |
| Sleep Apnea | 0.3 | 0.3 | |
| Small Intestinal Bacterial Overgrowth (SIBO) | 0.4 | 0.4 | |
| Stress / posttraumatic stress disorder | 0.4 | 0.4 | |
| Systemic Lupus Erythematosus | 0.8 | 0.8 | |
| Type 1 Diabetes | 0.5 | 0.5 | |
| Type 2 Diabetes | 0.9 | 0.2 | 3.5 |
| Ulcerative colitis | 0.9 | 0.9 | |
| Unhealthy Ageing | 0.3 | 0.3 |
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
The awesome web hosting site that we use. Try it if you need to host (or unhappy with current provider)